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Abstract 
Mesenchymal stem cells (MSCs) have attracted immense research interest in the field of 
regenerative medicine due to their ability to be cultured for successive passages and multi-lineage 
differentiation. The molecular mechanisms governing MSC self-renewal and differentiation 
remain largely unknown. The development of sophisticated techniques, in particular clinical 
proteomics, has enabled researchers in various fields to identify and characterize cell specific 
biomarkers for therapeutic purposes. This study seeks to understand the cellular and sub-cellular 
processes responsible for the existence of stem cell populations in bone marrow samples by 
revealing the whole cell proteome of the clonal cultures of bone marrow-derived MSCs (BMSCs). 
Protein profiling of the MSC clonal populations was conducted by Two-Dimensional Liquid 
Chromatography/Matrix-Assisted Laser Desorption/Ionisation (MALDI) Mass Spectrometry 
(MS). A total of 83 proteins were identified with high confidence of which 11 showed differential 
expression between subpopulations, which included cytoskeletal and structural proteins, calcium 
binding proteins, cytokinetic proteins, and members of the intermediate filament family. This study 
generated a proteome reference map of BMSCs from the clonal populations, which will be 
valuable to better understand the underlying mechanism of BMSC self-renewal and differentiation.  
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Introduction 
Bone marrow-derived mesenchymal stem cells (BMSCs) offer an attractive source of adult 
mesenchymal stem cells (MSCs) for the purpose of tissue regeneration. The versatility and 
availability of these cells make them a potent resource for cell transplant therapies. Although 
the potential use of BMSCs in therapeutic applications is well documented, unlike 
haematopoietic stem cells, BMSCs are less characterized and knowledge of their underlying 
molecular and cellular events remains unclear. 
 
Previous studies suggest human BMSC populations, in vitro and in vivo, are morphologically 
and functionally heterogeneous. Several attempts have been made to identify cell surface 
markers for the purification of stem cells from the mixed BMSC populations. A panel of cell 
surface markers have been investigated in the MSC separation such as STRO-1, CD29, CD44, 
CD73, CD90, CD105, CD166 and MHC-1 [Gronthos et al., 2003; Kolf et al., 2007; Simmons 
and Torok-Storb, 1991].  However, all these putative mesenchymal markers are not uniquely 
expressed in stem cells and the quest to find typical markers that determine the fate and 
function of mesenchymal stem cells still remains active.   
 
In our previous study we focused on developing single-cell clones derived from BMSCs and 
investigated their clonal characteristics [Mareddy, et al., 2007]. Altogether, 14 clonal 
populations were established from three bone marrow stromal samples. The clones were 
grouped into fast-growing clones and slow-growing clones based on their proliferative 
capacities, which was to measure the time taken by the individual clones to reach 20 
population doubling. Upon differentiation five of six fast-growing clones were capable of 
differentiating towards osteogenic, chondrogenic and adipogenic lineages. However, the 
slow-growing clones showed limited differentiation potential and morphological changes 
associated with cellular senescence with extended duration in culture. Flow cytometric 
analysis found no obvious difference in the expression of the selected characteristic BMSC 
cell surface markers CD29, CD44, CD90, CD105, and CD166 between fast-growing and 
slow-growing clones  [Mareddy et al., 2007]. To understand the molecular mechanisms 
governing MSC self-renewal and differentiation, three fast-growing clones with tripotential 
differentiation capacity (designated stem cell clones ((SCCs)) and three slow-growing clones 
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with only unipotential differentiation capacity (designated non-stem cell clones (nSCCs)) 
were selected for this study to investigate the proteomic profiling of these distinct clonal 
populations.  
 
Proteomics is the study of protein complement and aims to identify and characterize the entire 
protein make up of a sample, whether originating from a cell, tissue type or whole organism. A 
comparative approach to proteomics allows for the discovery of potential biomarkers or 
therapeutic targets that exist at a functional level in the cell by highlighting protein differences 
between test and control samples [Lane, 2005]. Although proteomic analysis of human 
mesenchymal stem cells have been conducted previously [Foster et al., 2005; Park et al., 2007; 
Salasznyk et al., 2005], the comparison of proteomic profiles from distinct cell populations 
derived from clone culture of bone marrow samples has the potential to reveal proteins that are 
important to the differences observed between these populations. 
 
Materials and Methods 
 
Clone culture and characterization of BMSCs 
Protein profiling studies were conducted on the previously characterized SCCs (fast-growing with 
tripotential differentiation capacity) and nSCCs (slow-growing with unipotential differentiation 
capacity) derived from BMSCs as described in our previous study [Mareddy et al., 2007]. Three 
SCC and three nSCC clones were selected from three different BMSC sample. To narrow down the 
variations, each BMSC sample contained one SCC and one nSCC clone respectively. Bone 
marrow samples were obtained from osteoarthritis patients aged from 54-76 (2 females and 3 
males) under elective knee replacement surgery. Patients selected for this study stopped all 
anti-inflammatory medicine 10 days prior to the surgery. Great care was taken to avoid 
contamination with MSC from other sources. The source of bone marrow in the present study was 
from the femoral canal. As per the standard knee replacement operation procedure, the joint was 
opened followed by draining of synovial fluid and extensive lavage. A femoral drill hole was made 
through the distal femur and an intramedullary rod was passed into the femoral canal. The marrow 
that oozed out was aspirated by a syringe. Single-cell clone cultures were established by a limiting 
dilution method. The number of viable cells/mL was determined at each passage using a 
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haemocytometer.  A graph was plotted against time in culture for a single cell to reach a population 
of approximately 1 million cells, or to undergo 20 population doublings (PDs), to measure the 
proliferative ability. A visual examination of cell proliferation between SCCs and nSCCs was 
conducted by plating cells at 8th passage at a density of 8,000 cells per well in a twenty four well 
plate. After three days in culture the cells were fixed with 4% paraformaldehyde for 15 min and 
stained with crystal violet for 10 min.  Excess stain was washed away with tap water and after 
drying the plates were examined by microscopy.  
 
The expression of surface antigens against CD29, CD34, CD45, CD44, CD73, CD90, CD105, 
CD166, and major histocompatibility complex (MHC class I, and MHC class II) was characterized 
by fluorescent flow cytometry (FACS) using cells at sixth passage. Briefly, confluent cultures were 
harvested in 0.05% trypsin/EDTA for 1 min and pelleted at 1000 rpm for 10 min. Cells were 
re-suspended in FACS buffer (PBS + 0.1% (w/v) sodium azide + 1% (w/v) bovine serum albumin) 
and incubated with primary unconjugated antibodies (CD29, CD34, CD45, CD44, CD73, CD90, 
CD105, CD166, major histocompatibility complex (MHC class I, and MHC class II) (BD 
Biosciences, Clontech, Palo Alto, CA, USA) for 15 min at room temperature. The cells were then 
washed and incubated with secondary antibody (goat anti-mouse immunoglobulin G phycoerythrin 
conjugate, Jackson Immunoresearch laboratories, West Grove, PA, USA) for 15 min. The cells 
were then washed and analysed using flow cytometry on a FACS Calibur (Becton Dickinson, 
Cowley, Oxford, UK). Data was analysed using FCSExpressTM software. 
 
Proteomic analysis  
Preparation of cell lysis buffer 
The lysis buffer consisted of 7.5 M urea, 2.5 M thiourea, 12.5% glycerol, 62.5 mM Tris-HCl 2.5% 
(w/v) n-octylglucoside (octyl ά-D-glucopyranoside), 6.25 mM TCEP (Tris (2-carboxyethyl) 
phosphine hydrochloride), 1.25 mM protease inhibitor cocktail containing 
4-(2-aminoethyl)benzenesulfonyl fluoride (AEBSF), E-64, bestatin, leupeptin, aprotinin, and 
sodium EDTA. Stock Lysis Buffer was prepared according to the ProteomeLab™ PF 2D 
manufacturer’s protocol (Beckman Coulter, Fullerton, CA, USA).  All the above chemicals were 
biotechnology grade from Sigma Aldrich Pty (Castle Hill, New South Wales, Australia). 
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Sample preparation 
All SCC or nSCC clones were pooled for protein extraction. SCCs and nSSCs at passage 8 were 
plated at a density of 5×10³ cells/cm² in a 175 cm² flask were cultured in Dulbecco’s modified 
Eagle medium with low glucose (DMEM-LG) (GIBCO, Invitrogen Corporation, Australia) 
supplemented with batch tested 10% (v/v) foetal bovine serum (FBS) and 5% 10 U/mL penicillin G 
and 10 µg/mL streptomycin (GIBCO). The cells were incubated at 37ºC in a humidified condition 
containing 5% CO2.  Eight flask cells from SCCs or nSCCs were pooled together and washed 
twice in Dulbecco’s phosphate buffered saline, DPBS (GIBCO).  A total volume of 500 µL of the 
cell pellet was suspended in 2 mL of lysis buffer containing 1.25 mM protease inhibitor cocktail 
and vortexed rigorously.  The suspension was centrifuged at 20,000 g for 60 min at 18ºC.  The 
resulting supernatant was stored at -80ºC until further use. Protein concentration was determined 
with a BCA™ protein assay kit (Pierce, Quantum Scientific, QLD, Australia) on the sample lysate 
after exchange with Start Buffer on a PD-10 size exclusion column (GE Healthcare Biosciences, 
NSW, Australia).   
 
1st-Dimension separation – Chromatofocusing 
First and second dimension separations were based on the ProteomeLab ™ PF 2D default method 
[Betgovargez et al., 2005]. Start and Eluent Buffers, supplied in the PF 2D chemistry kit (Beckman 
Coulter), were sonicated for 5 min and pH adjusted to 8.5 ± 0.1 and 4.0 ± 0.1 with saturated 
iminodiacetic acid (Sigma) and 1 M NH4OH accordingly. Chromatofocusing was performed at 
ambient temperature with a flow rate of 0.2 mL/min, and absorbance of the column effluent was 
monitored at 280 nm. The chromatofocusing column was first equilibrated with 30 volumes of 
Start Buffer, after which 3.2 mg of protein sample, previously exchanged into Start Buffer, was 
injected onto the column. Proteins were then fractionated by their isoelectric point (pI) over a 
chromatographic pH gradient of pH 8.5 to pH 4.0.  Liquid fractions were collected at 0.3 pH 
intervals during the pH gradient and at 5 min intervals at all other times. The first dimension 
fractions were collected into a 96 well plate by the combination fraction collector/auto-injector 
(FC/I).   
 
2nd -Dimension separation - High Performance Reversed-Phase Chromatography 
 8
The pI fractions from the first dimension were sequentially injected onto the second dimension 
high performance reverse phase liquid chromatography column as specified in the ProteomeLab™ 
PF 2D user manual. The first dimension fractions were separated based on their hydrophobicity 
over a solvent gradient of H2O / 0.1% Triflouroacetic acid (TFA), (Solvent A) and acetonitrile / 
0.08% TFA, (Solvent B). HPLC grade acetonitrile and TFA were purchased from Sigma Aldrich 
Pty (NSW, Australia). The second dimension separation was performed at 50ºC at a flow rate of 
0.75 mL/min and column eluent absorbance was measured at 214 nm. The column was first 
equilibrated with 10 volumes of 100% Solvent A. From each first dimension fraction 200 µL was 
injected and the column was eluted with a gradient of 0-100% Solvent B. The reversed phase 
fractions were collected at a rate of 1 min/fraction into 96-deep well plates for subsequent 
processing and digestion with trypsin for analysis by mass spectroscopy, without any additional 
extraction or solubilisation of the sample with other fractionation techniques.  
 
Data analysis  
UV absorbance profiles, appearing similar to 2-D gels, were generated for each of the SCCs 
(fast-growing) and nSCCs (slow-growing) separations using the ProteoVue application of the 
ProteomeLab™ PF 2D Software Suite 1.0. A comparison of the UV absorbance profiles for SCCs 
and nSCCs was performed using the DeltaVue application of the software suite. The peak picking 
analytical tool of the DeltaVue software enabled semi-quantitation of differences in UV 
absorbance between the clone profiles and the results were displayed as fold changes. 
 
Sample preparation and mass spectrometry 
Selected reversed phase fractions were concentrated using a Speed Vac concentrator (Thermo 
Savant) and subsequently reduced by treating each fraction with 100 µL 0.1 M NH4CO3, pH 7.9 and 
20 mM DTT (Sigma Aldrich) and incubated for 1 h at 56°C.  Samples were then alkylated by 
adding 0.5 M iodoacetamide stock (Sigma Aldrich) for a final concentration of 50 mM in each tube 
and incubated for 30 min at 37°C in the dark.  All the samples were digested with sequencing grade 
modified trypsin (Promega, NSW, Australia), by adding 0.1 μg/µL stock to a final concentration of 
2 ng/µL and incubated overnight at 37°C. The tryptic peptides were then desalted using 
PerfectPure C-18 tips (Eppendorf, Quantum Scientific, Brisbane, Australia) and 0.4 µL of each 
sample was applied to a MALDI target plate (96 × 2 spot ABi 4700 target), which had been spotted 
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just prior with 0.4 µL of ά-cyano-4-hydroxy-trans-cinnamic acid (CHCA) matrix (Sigma) at a 
concentration of 5 mg/mL in 60% acetonitrile, 0.1% TFA. The spots were air dried and 
MALDI-TOF/TOF-MS analysis was performed using a 4700 Proteomics Analyser mass 
spectrometer (Applied Biosystems) operated in positive ion reflectron mode. MS data were 
calibrated using a plate wide external calibration using the 4700 Mass Standards Kit (Applied 
Biosystems) containing des-Arg-Bradykinin (MH+ 904.458, Angiotensin I (MH+ 1296.685) 
Glu-fibrinopeptide B (MH+ 1570.677) ACTH (1-17 clip, MH+ 2093.087), ACTH (18-39 clip, MH+ 
2465.199) and ACTH (7-38 clip, MH+ 3657.929). MS/MS data were calibrated against the MS/MS 
fragments of the m/z = 1296.685 Angiotensin I peptide in the standards. MS data was acquired 
using 2000 shots. The top 10 most intense peptides detected in each spot in MS mode were 
automatically selected for MS/MS analysis using 3000 laser shots.  
 
Peptide identification 
The MASCOT (Matrix Science) search engine was used to deconvolute the raw mass spectra to 
obtain a list of probability-based protein/peptide matches for each of the samples. The MSDB 
database was selected and taxonomy restricted to Homo sapien; trypsin cleavage specificity was 
allowed one missed cleavage, peptide tolerance was limited to 50 ppm, modifications were set to 
carbamidomethylation of cysteine (fixed), and oxidation of methionine (variable).  
 
Western blot analysis 
Three SCC and nSCC samples were validated by the protein expression. Total protein lysate (5 µg) 
from SCCs and nSCCs cultures at passage 8, were separated by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a nitrocellulose 
membrane. The blots were blocked with Tris-buffered saline containing 0.1% Tween20 and 5% 
non-fat milk, followed by incubation with primary antibodies against calmodulin (CAM) (mouse 
anti-human, Millipore, NSW, Australia), heat shock protein 27 (HSP27) (rabbit anti-human, Bio 
Scientific Pty, NSW, Australia)  and alpha tubulin (TUB) (mouse anti-human, Abcam, Sapphire 
Bioscience, NSW, Australia) at 1: 1000 dilution. The bound primary antibodies were detected by 
using a goat anti-mouse for CAM and TUB and goat anti-rabbit IgG-horseradish peroxidase 
conjugated antibody for HSP27 (1: 1000) and bands were visualized by electrogenerated 
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chemiluminescence (ECL). Band intensity of CAM and HSP27 was measured and normalised via 
the expression of TUB. 
 
Immunocytochemistry 
Clonal cultures at passage 9 were plated at a density of 3000 cells/well on 8-well chamber slides 
(nunc, In Vitro Technologies Pty Ltd, Victoria). The cells were allowed to attach overnight at 37ºC 
in a CO2 incubator, and fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) for 15 
min, followed by permeabilization with 0.5% triton X-100 in PBS for 10 min. Non-specific protein 
binding was blocked by incubation with 1:10 normal swine serum in PBS containing 0.1% bovine 
serum albumin (BSA) for 30 min. The cells were immunostained against CAM, HSP27 and TUB 
(positive control) by incubating with a 1:1000 primary antibody dilution in PBS with 0.1% BSA at 
4ºC overnight. Cells were then incubated with a biotinylated swine-anti-mouse, rabbit, goat 
antibody (DAKO Multilink, CA, USA) for 15 min, and then incubated with horseradish 
perioxidase-conjugated avidin-biotin complex (ABC) for 15 min.  Antibody complexes were 
visualized after the addition of a buffered diaminobenzidine (DAB) substrate for 4 min.  The 
reaction was stopped by immersion and rinsing of sections in PBS.  Cells were then lightly 
counterstained with Mayer’s haematoxylin and Scott’s Blue for 40 seconds each, in between 3 min 
rinses with running tap water.  Following this, the cells were dehydrated with ascending 
concentrations of ethanol solutions, cleared with xylene and mounted with a cover slip using 
DePeX mounting medium (BDH Laboratory Supplies, England). Control for the 
immunocytochemical cell staining procedures included conditions where the primary antibody was 
omitted.   
  
Quantitative RT-PCR (qRT-PCR) 
Total RNA was isolated from SCCs and nSCCs cultures at passage 9 using Tri Reagent (Sigma) 
following the suppliers instructions. RNA concentration was measured by photometric 
measurement. Total RNA (1 μg) was reverse transcribed into 20 l cDNA using SuperScript III 
(Invitrogen) following the manufacturers protocol. Real-time PCR was performed in 25 μL 
reactions containing 12.5 μL SYBR green Master Mix (Applied Biosystems), 2.5 μL (10 μM) of 
each forward and reverse primer for each gene of interest for a final concentration of 20 pmol, 2.5 
μL of cDNA template and RNA free water. Reactions were performed in triplicates to determine 
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the expression of genes using primers (Table 1) for CAM, HSP27 and CALD1. The house keeping 
gene, 18S rRNA was used as a control. The reaction was carried out using ABi Prism 7000 
Sequence Detection System (Applied Biosystems) and the PCR amplification followed 1 cycle of 
30 min at 48˚C, 1 cycle of 10 min at 95˚C, 40 cycles of 15 s at 95˚C and 60˚C for 1 min. Melting 
curve analysis was performed to validate specific amplicon amplification without genomic DNA 
contamination. Relative expression levels for each gene were normalized by the Ct value of the 
house keeping gene 18S rRNA and determined by using the ΔCt method. The genes for CAM, 
HSP27 and CALD1 were selected for real time-PCR analysis due to their high relevance to cell 
integrity and confident mass spectrometry identifications. The relative expression of each gene was 
analysed by one-way ANOVA and Student-Newman-Keuls (SNK) q-test. The significant 
difference was considered at p<0.05.  
 
 
Results  
 
In our previous study SCCs have been demonstrated to be able to differentiate to osteogenic, 
chondrogenic and adipogenic lineages, whereas nSCCs showed limited differentiation [Mareddy, 
et al., 2007]. In this study three SCCs and three nSCCs clones were selected to further compare 
their growth kinetics. At 8th passage, SCCs clones demonstrated fast-growing ability after plating 
in tissue culture well for three days compared with nSCCs (Figure 1A). The time for SCCs to reach 
20 PDs was significantly shorter than nSCCs (p=0.0116) (Figure 1B).  FACS analysis revealed that 
all the clones were positive for mesenchymal cell surface epitopes (CD29, CD44, CD73, CD90, 
CD105, and CD166) and negative for haematopoietic cell surface epitopes (CD34 and CD45). 
Furthermore, all the clones expressed MHC class I but were negative for MHC class II. There was 
no significant difference between the two types of clones in the expression of these cell surface 
markers (p>0.05) (Figure 1C).  
 
 
Differential protein expression profile of clonal populations 
Pooled proteins from SCC and nSCC samples were used for the study of protein expression profile 
of SCCs and nSCCs. Two dimensional proteomic profiles of the pooled SCC (Figure 2A) and 
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nSCC (Figure 2B) samples were obtained from 2D-LC fractionation. Identifiers located on the 
proteome maps indicate identified proteins (see below). Each lane represents the UV absorbance 
(214 nm) intensity of the reversed-phase high-performance chromatography separation for each 
fraction collected in the chromatofocusing separation. The pI window for each fraction is detailed 
at the top of each lane and the reversed-phase retention time is detailed at the left. The fractions 
resulting from reversed phase separation of SCCs and nSCCs exhibited differences in the 
expression of proteins in the order of fold changes ranging from 1 to 5. Based on these fold 
differences, fractions with a fold change greater than 1.5 were selected for further analysis with 
MALDI-TOF/TOF-MS. The identity of the resulting proteins were then determined by comparing 
the masses obtained by MS and MS/MS analysis to the theoretical masses of in silico digested 
proteins using a MASCOT (Matrix Science Ltd.) database search.  
 
The MS results depicted a high abundance of proteins belonging to the intermediate filament 
family, cytoskeletal components, calcium-binding proteins and metabolic enzymes. Essentially the 
proteins which showed a MOWSE (molecular weight search) protein score above 64 were further 
ranked by peptide fragmentation mass fingerprint (PFMF) scores when considering protein 
identification. The proteins calmodulin (CAM) and heat shock protein 27 (HSP27) were 
unequivocally identified by PFMF. A total of 83 proteins representing 196 second dimension 
liquid fractions were identified in this study (Tables 2). The location of identified proteins on 
proteome reference maps can be observed in Figure 2 using the identification numbers in column 1 
of Table 2.  The molecular function and biological processes of these proteins were assigned 
according to information found in the Swiss-Prot and NCBI protein databases. A group of 6 
proteins were expressed repeatedly in more than one non-sequential fraction, suggesting these 
proteins may have undergone post translational modification. Altogether, 11 proteins of specific 
interest were identified by MS, with high protein and ion score intervals, which were differentially 
expressed between SCCs and nSCCs (Table 3). Among them, three were up-regulated in SCCs and 
8 up-regulated in nSCCs. These proteins included cytoskeletal, cytokinetic, stress related proteins 
and proteins of energy and signalling pathways.  
 
Functional grouping 
In the list (Table 2) of protein species identified, 52% are involved in biological processes such as 
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cellular organization, which included cytoskeletal and structural, calcium binding proteins, 
cytokinetic and members of intermediate filament family. Other proteins identified were 
membrane proteins (11%), metabolic enzymes (13%), endocrine proteins (7%), transport proteins 
(2%), stress proteins (2%) and some unknown proteins (13%).   
 
The three most frequently observed proteins in SCCs were calmodulin (CAM) and tropomyosin 
(TM), which are intermediate filament proteins and corticotropin secreted by the pituitary gland 
(Table 3). The eight most abundant proteins in nSCCs were caldesmon (CAD), annexin 1, lamin 
A/C, progerin, metabolic pathway enzymes, glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH), enolase and pyruvate kinase M2 and a stress related protein, HSP27 (Table 3). 
Vimentin, a structural protein was found abundantly in both groups of clones.  
 
Confirmation studies  
Proteomics findings were evaluated in SCC and nSCC clonal populations derived from original 
sample, as well as two additional patient samples. Results were validated by the mRNA expression 
using quantitative PCR for CAM, CAD, and HSP27; protein expression using western blot analysis 
and immunocytochemical cell staining for the proteins CAM and HSP27. The mRNA and protein 
results were analogous to the protein presentation observed in proteomic study when comparing the 
clonal populations. The mRNA expression of CAM was significantly upregulated in SCCs 
compared to nSCCs; whereas mRNA expression of CAD and HSP27 was significantly 
downregulated in SCCs (Figure 3A). Western blot analysis results showed CAM was highly 
expressed in SCCs (Mean intensity: 0.67, SD: 0.12) compared with the expression in nSCCs (Mean 
intensity: 0.41, SD: 0.09), whereas HSP27 was expressed more in nSCCs (Mean intensity: 0.71; 
SD: 0.2) and SCCs (Mean intensity 0.35; SD: 0.20) (Figure 3B). Immunocytochemical staining of 
CAM and HSP27 further demonstrated the distribution of CAM in SCCs and HSP27 in nSCCs. 
Tubulin, which was used as a control was distributed equally in both SCCs and nSCCs. No staining 
was detected in the negative control (Figure 4).  
 
 
Discussion 
Cell based therapies rely to a large degree on the preparation of an effective dose of ex vivo 
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expanded cells capable of self-renewal and differentiation. Identifying cells of physiological 
relevance forms an integral part of the emerging field of tissue engineering. During the past decade 
there has been an increase in research activity aimed at understanding cellular and molecular 
aspects of cell proliferation and differentiation of various sources of stem cells [Blonder et al., 
2006; Feldmann et al., 2005; Golan-Mashiach et al., 2004; Hermansson et al., 2004; Panepucci et 
al., 2004; Wang et al., 2004]. Irrespective of stem cell source, cell quality for in vitro expansion is 
defined by certain desirable parameters. Cell proliferation rates need to be high in order to reach a 
sufficient quantity of cells for practical transplantation that can readily differentiate upon 
induction. A large volume of research has focused on finding subpopulations of cells which meet 
these criteria and then to identify specific markers which could enable isolation of such cells. A 
growing body of research indicates a need for, but a lack of, rigorous standards for characterizing  
human MSCs, and thus makes it difficult to compare data from different investigators [Banfi et al., 
2000; Muraglia et al., 2000; Phinney et al., 1999]. Fewer studies have focused on protein 
expression profiles of the differentiation pathways of MSCs [Blonder et al., 2006; Hermansson et 
al., 2004; Sun et al., 2006; Ye et al., 2006]. Sun et al (2006) conducted proteome analysis on 
serially subcultured MSCs during osteogenic differentiation from heterogeneous starting 
populations. They concluded that proteomic studies should ideally be conducted on colonies 
derived from a single cell origin, although such a procedure faces the limitation of cell 
number/quantity [Sun et al., 2006]. To our knowledge no proteomic studies have been conducted 
on the sub-populations derived from the heterogeneous bone marrow stromal cells. Our study is 
based on populations derived from single cells and which can therefore be assumed to be 
genetically homogenous, at least to begin with. To make up for the low quantity of cells, clonal 
populations were serially cultured up to 28 population doublings. No cytogenetic abnormalities 
were detected in all clone populations when SCC and nSCC cells were karyotyped (data not 
shown), which indicates a potential cell population (SCCs) for transplantation study.  The protein 
expression profiles presented here is therefore a reflection of the cells at a higher passage number, 
and hence the predominant expression of proteins involved in maintaining cellular integrity.  
 
In our previous work we have demonstrated the existence of different sub-populations within the 
bone marrow stromal cells by isolating and expanding single-cell clonal populations [Mareddy et 
al., 2007]. The present study is a logical extension of our previous work in order to determine if the 
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varying proliferation rates and differentiation potentials, seen between the fast- and slow-growing 
clones, were due to the expression of specific proteins. 
 
For this investigation the authors selected three SCC clones and three nSCC clones. To narrow 
down the variation from patient’s factors, each BMSC sample contained one SCC and one nSCC 
clones respectively. All SCC or nSCC clones were pooled for protein extraction and subsequent 
proteomic analysis. This is because protein fractionation by two-dimensional liquid 
chromatography (2D-LC), while offering improvements over two-dimensional gel electrophoresis 
in protein identification, requires substantially more total protein. Therefore, the current proteome 
expression generated from the pooled samples only reflected the difference between SCC and 
nSCC clones, but could not show differences within the three SCC or nSCC clones.  The result 
yielded over 170 protein identities in the 196 liquid fractions assessed, for the purpose of the 
manuscript only the most confident results were included. Our proteomic analysis highlighted 
protein map found to be differentially expressed between SCCs and nSCCs. Comparative UV 
protein peaks which showed a fold change between 2 and 5 from the 2D liquid chromatography 
analysis were selected for further MALDI- TOF/TOF-MS identification. Of particular interest was 
the expression differences of proteins related to cell cycle, cell morphology, metabolism and 
proliferation. An over expression of calcium-binding and actin-binding proteins, such as CAM and 
TM, was evident in the fast-growing SCCs, which is particularly interesting since CAM regulates 
apoptosis in many cell types by binding to the death receptor Fas and thus blocking the 
Fas-mediated apoptosis [Ahn et al., 2004]. In addition, Ca2+/CAM (calcium bound calmodulin) is 
known to play a vital role in releasing the brakes in CAD-regulated cytokinesis which affects the 
rate of cell division [Eppinga et al., 2006]. CAM also modulates osteoclastogenesis and therefore 
bone resorption during bone turnover [Zhang et al., 2003]. TM is reported to promote cytokinesis 
progression by stimulating the activation of actomyosin ATPase, which is required to accelerate 
cell division [Eppinga et al., 2006]. The potential over expression of CAM and TM in the 
fast-growing SCCs can be attributed to their role as modulators during cytokinesis and cell 
proliferation.   
 
Corticotropin, a peptide hormone secreted by the pituitary gland, was another protein found to be 
over represented in the fast-growing SCCs. This hormone has a role in modulating the immune 
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system by reducing the production of immunoglobulin by B-lymphocytes [Tsagarakis and 
Grossman, 1994]. Corticotropin treatment is reported to increase the proliferation of multipotential 
progenitor populations and also promote the development of a chondrocyte phenotype from 
multipotential progenitor populations [Evans et al., 2004]. Furthermore, corticotropin is known to 
stimulate keratinocyte proliferation thus playing a role in wound healing and also to activate the 
epithelial and mesenchymal cell proliferation and differentiation throughout the parenchyma 
during pulmonary maturation [Muglia et al., 1999].  
 
Proteins found to be over expressed in slow-growing nSCCs included members of metabolic 
pathways, stress response and cytoskeletal proteins. Among these proteins, the role of CAD is of 
particular interest, since it binds to actin, myosin, and TM and inhibits TM-actin-activated myosin 
ATPase, establishing a regulated break to cytokinesis. TM and CAD are thought to play opposing 
roles in the regulation of actin-activated myosin during cytokinesis, and there appears to be a strong 
correlation between the state of myosin ATPase and rate of cell division [Eppinga et al., 2006]. 
Annexin-I (ANAX1) and annexin-2 were another two anti-proliferative proteins highlighted by our 
proteomics analysis, which belong to the family of phospholipids and calcium-binding proteins 
associated with membrane, cytosol and cytoskeleton in a calcium-dependent manner. ANAX1 is 
reported to have a cell-type independent, anti-proliferative function through sustained activation of 
ERK (extracellular signal-regulated kinases) signalling cascade and by disruption of the actin 
cytoskeleton. Over expression of ANAX1 inhibits cyclin D1 expression affecting the normal cell 
morphology and therefore reducing the cell proliferation [Alldridge and Bryant, 2003]. Nuclear 
protein export is another important mechanism that regulates cell cycle transition. Nuclear 
retention of annexin II reduces cell proliferation and increases population doubling time. 
Expression of annexin II also causes morphological changes of the cells [Liu et al., 2003].  
 
The elevated expression of proteins of the nuclear lamina, lamin A/C and progerin - the mutant 
form of lamin A - are also of high relevance to our study. Previous studies suggest that lamin A, and 
its C isoform, are predominantly expressed in differentiated cells and are dispensable during 
embryonic development, at least in the mouse [Gotzmann and Foisner, 2006; Mattout et al., 2006]. 
Furthermore, the expression of progerin in interphase cells is associated with lobulation of the 
nuclear envelope, thickening of the nuclear lamina and destabilization of cytokinesis, nuclear 
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assembly and the cell cycle itself [Dechat et al., 2007]. HSP27, an ATP-independent chaperone that 
confers cytoprotection and the support of cell survival under stress conditions, was found to have 
an increased expression in the slow clones. In response to stress stimuli, expression and 
phosphorylation of HSP27 is increased [Rogalla et al., 1999] which in turn potentiates the 
degradation of ubiquinated proteins in vitro [Parcellier et al., 2003].  
 
Besides the up-regulation of the cell cycle regulatory proteins mentioned above, metabolic 
pathway proteins, such as GAPDH and pyruvate kinase M2 (PKM2), were also found to have an 
increased expression. GAPDH is a glycolytic protein, which is pivotal in energy production, but 
which is now known to have other functions, seemingly independent of its role in glycolysis [Epner 
et al., 1999]. For example, GAPDH appears to play a critical role during apoptosis, in a variety of 
cell types, [Ishitani et al., 1996; Sunaga et al., 1995] by translocating to the nucleus, thereby acting 
as a signalling mechanism which activates transcription of pro-apoptic proteins. It has also been 
reported that nuclear translocation of PKM2 is sufficient to induce cell death that is independent of 
any caspase isoforms and enzymatic activity [Stetak et al., 2007]. Interestingly, observations have 
been made with regard to metabolic rate and its inverse proportionality to stem cell self-renewal 
[Sastry, 2004], which may possibly explain the abundant expression of the metabolic enzymes in 
slow-growing nSCCs; an indication of these cells reaching a Hayflick limit [Shay and Wright, 
2000] . In a study employing autofluoresence spectroscopy it was revealed that cells with high 
metabolic activity had a corresponding high rate of cell differentiation, and low metabolic activity 
corresponded with self-renewal [Croce et al., 1999]. These techniques open up new alternative 
possibilities of separating out viable self-renewing cells in the absence of definitive cell surface 
molecular markers.  
 
In conclusion, the protein profiling study of distinct cell populations, derived from the 
heterogeneous bone marrow stromal cells, has generated a proteome reference map of stem cell 
clones, which will provide valuable information for the understanding of stem cell self-renewal and 
differentiation. The identified proteins and their crosstalk appear to confer the altered status in 
which the cell populations exist. Of particular interest was the differential presentation of 
calmodulin, tropomyosin and caldesmon between SCCs and nSCCs.  These proteins could be 
prospective molecular markers of different sub-populations found in bone marrow cells. Future 
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studies will examine the functional properties of these molecules in MSC self renewal and 
differentiation. 
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Tables 
 
Table 1: Primer pairs used for qRT-PCR. 
 
Table 2:  Protein expression profile of SCCs and nSCCs separated by 2D LC and identified by 
MALDI-TOF/TOF-MS. The location of identified proteins on proteome reference maps can be 
observed in Figure 2 using the numbers under ID# from Fig. 2. 
 
Table 3:  Proteins of specific interest with differential expression between SCC and nSCC 
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Figure Legends 
 
Figure 1: Growth and surface marker characterisation of SCCs.  
A) Morphologically no significant difference was noted between SCCs (a) and nSCCs (b), but 
increased cell number was visually observed in SCCs compared with nSCCs after three days in 
culture with the same seeding density (10 X magnifications). B) The chart indicates the time taken 
by SCCs and nSCCs (n=3) to complete 20 population doublings (PDs). SCCs reached a population 
of one million cells (approximately 20 PDs) within 55 days whereas nSCCs took more than 88 days 
(p=0.018). C) Flow cytometry analysis of surface epitopes in bone marrow derived clone cultures. 
Clone cultures were labelled with phycoerythrin or fluorescein isothiocyanate-conjugated 
antibodies against putative mesenchymal (CD29, CD44, CD73, CD90, CD105, CD166), 
haematopoietic (CD34 and CD45), major histocompatibility complex (MHCI and MHCII) and 
immunoglobulin (Ig) isotope controls. The chart shows that there was no significant difference in 
the expression of these surface markers between SCCs and nSCCs. Error bars reflect the mean 
(±SD) across 3 SCCs and 3 nSCCs. 
 
Figure 2: Two dimensional proteomic profiles of the pooled SCC (A) and nSCC (B) samples 
obtained from 2D-LC fractionation. Each lane represents the UV absorbance (214 nm) intensity of 
the reversed-phase high-performance chromatography separation for each fraction collected in the 
chromatofocusing separation. The pI window for each fraction is detailed at the top of each lane 
and the reversed-phase retention time is detailed at the left. Crosshairs (+) designate proteins which 
were found to have differential presentation and were subsequently identified by mass 
spectrometry (see Table 2). 
 
Figure 3: Confirmation of the differential expression of proteins identified in the proteomic study. 
(A) mRNA expression of calmodulin (CAM), caldesmon (CAD) and heat shock protein 27 
(HSP27) was quantified by qRT-PCR. The figure shows the relative mRNA expression for each 
gene in comparison to the expression of the house keeping gene, 18S rRNA. CAM indicated up 
regulation in SCCs and CAD and HSP27 showed increased expression in nSCCs. (B) Western blot 
analysis of CAM and HSP27 in SCCs and nSCCs. CAM was highly expressed in the SCCs 
compared with the expression in nSCCs, whereas HSP27 was expressed more in nSCCs The 
housekeeping gene alpha tubulin (TUB) was uniformly expressed in all the clones.  
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Figure 4: Differential expression of CAM and HSP27 between the clonal populations as revealed 
by immunocytochemistry (10X magnification). For immunostaining cells were permeabilized and 
incubated with primary antibodies, CAM, HSP27 and TUB overnight. The upper panel (A-D) 
displays the results for SCCs which showed strong staining for CAM and weak staining for HSP27. 
Similarly, the lower panel (E-H) displays the differential expression of nSCCs which showed 
strong staining for HSP27 and weak staining for CAM. Both the clones uniformly expressed the 
protein for house keeping gene TUB. No staining was detected in the negative control (D and H). 
 
 
